Related topics

Intra-Cellular: 3Q Earnings Snapshot

November 5, 2019 GMT

NEW YORK (AP) _ Intra-Cellular Therapies Inc. (ITCI) on Tuesday reported a loss of $34.9 million in its third quarter.

The New York-based company said it had a loss of 63 cents per share.

The results topped Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 86 cents per share.

Intra-Cellular shares have decreased 16% since the beginning of the year. The stock has declined 48% in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ITCI at https://www.zacks.com/ap/ITCI